Sort by
Refine Your Search
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Portugal | about 2 months ago
oncogenic receptor ErbB2/HER2 remains a major therapeutic molecular target. However, the emergence of resistance through yet elusive molecular mechanisms drastically undermines the therapeutic efficacy
-
for equipping modern operating systems with expressive, low-overhead observability mechanisms, enabling the state of the kernel (e.g., processes, network, files) to be queried through a high-level declarative
-
to the technological frontier, namely: (i) the efficiency of market selection mechanisms, (ii) the role of changes in firm size and business restructuring, and (iii) firms’ behaviour in a context of successive and
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Portugal | 3 months ago
resistance to the effects of BS. Thus, the project aims to deepen the understanding of the epigenetic mechanisms underlying the success of BS, contributing to the identification of predictive biomarkers